Reuters Cell & Gene Therapy USA 2022 – RWE for Market Access
By Innomar Strategies
Measuring the Impact of real-world evidence in payor assessments
RWE plays an important role to enhance value demonstration to payers. Tune into the panel discussion from this year’s Cell & Gene Therapy USA conference to understand the use of real-world evidence in payor discussions and more broadly with respect to market access.
Enter your information below to watch the video.
